Kujawsko-Pomorskie Centrum Urologicznw Sp z o.o
- Address
- Ul. Stefana Batorego 18-22, 87-100 Torun, Poland
Kujawsko-Pomorskie Centrum Urologiczne - Urological Research Center
Kujawsko-Pomorskie Centrum Urologiczne is a specialized urological research center dedicated to advancing the treatment and management of urological cancers. The center focuses on innovative therapeutic approaches and participates in international clinical trials to improve outcomes for patients with complex urological conditions.
- High-risk nonmetastatic prostate cancer treatment strategies
- Advanced hormonal therapies and combination treatments for prostate cancer
- Post-definitive therapy disease progression management
The center has particular expertise in evaluating enzalutamide-based therapeutic regimens in combination with androgen deprivation therapy for men with prostate cancer. Their research contributes to understanding optimal treatment approaches for patients experiencing disease progression after definitive therapy, helping to establish evidence-based protocols for high-risk nonmetastatic prostate cancer management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Kujawsko-Pomorskie Centrum Urologicznw Sp z o.o
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Enzalutamide and Leuprorelin Acetate in High-Risk Nonmetastatic Prostate Cancer Post-Definitive Therapy | Medivation Inc. | Phase III | Not Recruiting | Aug 2015 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Enzalutamide | 1 | Unknown | 2015-08-19 | 2015-08-19 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.